Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program

被引:0
作者
Gita Shafiee
Ramin Heshmat
Afshin Ostovar
Fatemeh Khatami
Noushin Fahimfar
Seyed Masoud Arzaghi
Safoora Gharibzadeh
Sara Hanaei
Iraj Nabipour
Bagher Larijani
机构
[1] Tehran University of Medical Sciences,Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute
[2] Tehran University of Medical Sciences,Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[3] Tehran University of Medical Sciences,Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute
[4] Tehran University of Medical Sciences (TUMS),Research Center for Immunodeficiencies (RCID)
[5] Universal Scientific Education and Research Network (USERN),The Persian Gulf Tropical Medicine Research Center
[6] Bushehr University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[7] Tehran University of Medical Sciences,undefined
来源
Journal of Diabetes & Metabolic Disorders | 2020年 / 19卷
关键词
Prevalence; Sarcopenia; EWGSOP-1; EWGSOP-2;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:727 / 734
页数:7
相关论文
共 108 条
[1]  
Cruz-Jentoft A(2010)Sarcopenia: European consensus on definition and diagnosis. Report of the European Workign Group on Sarcopenia in Older People Age Ageing 39 412-23
[2]  
Cruz-Jentoft AJ(2019)Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 48 601-33
[3]  
Bahat G(2017)Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies Journal of diabetes metabolic disorders 16 21-56
[4]  
Bauer J(2010)An overview of sarcopenia: facts and numbers on prevalence and clinical impact J Cachexia Sarcopenia Muscle 1 129-101
[5]  
Boirie Y(2011)Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia J Am Med Dir Assoc 12 249-74
[6]  
Bruyere O(2014)Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia J Am Med Dir Assoc 15 95-31
[7]  
Cederholm T(2019)Sarcopenia disease in Iran: an overview J Diabetes Metab Disord 18 665-24
[8]  
Shafiee G(2018)Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 48 16-73
[9]  
Keshtkar A(2020)Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents Exp Gerontol 130 110798-56
[10]  
Soltani A(2019)Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis BMC Musculoskelet Disord 20 615-52